Dr. Kosala Samarasinghe, MD

Dr. Samarasinghe practices at Scripps Coastal Medical Center in San Diego, California.

Dr. Samarasinghe's NPI, 1386626034, was assigned on November 17, 2005. Dr. Samarasinghe graduated from American University of the Caribbean School of Medicine in 1998. Dr. Samarasinghe holds California license A80809.

Dr. Samarasinghe's primary practice is Scripps Coastal Medical Center, at 501 Washington St Suite 508 Suite 508, San Diego, CA 92103-2238. The practice phone is (619) 849-4469.

Dr. Samarasinghe's primary practice is Scripps Coastal Medical Center in San Diego, California. Dr. Samarasinghe is also affiliated with Scripps Mercy Hospital San Diego. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Samarasinghe to 2 more hospitals and 3 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samarasinghe practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Samarasinghe's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Samarasinghe is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Samarasinghe's licenses on file in 3 states: California, Ohio and New York.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, adjustment disease, aneurysm, ankle or foot injury, anxiety and aortic atherosclerois among the conditions Dr. Samarasinghe treats.

CMS data shows 2,111 Medicare services from Dr. Samarasinghe across 20 procedure codes in 2024, for 384 Medicare patients. Medicare paid $169,905 for them. Every service was in an office.

CMS counts 384 Medicare patients who saw Dr. Samarasinghe in 2024. The largest group is 75 to 84, with 164 patients. 68% of them have high cholesterol, and 66% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Samarasinghe's median patient age at 66, with 43% women.

In 2024, Dr. Samarasinghe wrote 3,362 Medicare Part D claims for 361 patients. 90% of them were for generic drugs. CMS names the drug for 2,682 of them, across 66 drugs with 11 or more claims each, at $116,768 in total drug cost. In 2023, CMS named 3,129 claims across 82 drugs.

Dr. Samarasinghe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samarasinghe as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 90 general payments to Dr. Samarasinghe from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $927.

Dr. Samarasinghe graduated from American University of the Caribbean School of Medicine in 1998.

Dr. Samarasinghe is in network with 7 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.